Quantum-Si Appoints New Director and CSO
Ticker: QSIAW · Form: 8-K · Filed: Mar 21, 2024 · CIK: 1816431
| Field | Detail |
|---|---|
| Company | Quantum-Si Inc (QSIAW) |
| Form Type | 8-K |
| Filed Date | Mar 21, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001, $11.50 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, board-appointment, executive-appointment
Related Tickers: QSI
TL;DR
Quantum-Si adds a new director and CSO, potentially signaling R&D focus.
AI Summary
Quantum-Si Incorporated announced on March 20, 2024, the election of Dr. Christian Ellinger as a Class II director and the appointment of Dr. Jonathan Rothberg as Chief Scientific Officer. The company also disclosed compensatory arrangements for certain officers, though specific dollar amounts were not detailed in this filing.
Why It Matters
The appointment of a new director and a Chief Scientific Officer can signal strategic shifts or a renewed focus on research and development for Quantum-Si.
Risk Assessment
Risk Level: low — This filing primarily concerns board and executive appointments and compensatory arrangements, which are routine corporate governance matters.
Key Players & Entities
- Quantum-Si Incorporated (company) — Registrant
- Dr. Christian Ellinger (person) — Elected Class II Director
- Dr. Jonathan Rothberg (person) — Appointed Chief Scientific Officer
- March 20, 2024 (date) — Date of earliest event reported
FAQ
Who was elected as a Class II director for Quantum-Si?
Dr. Christian Ellinger was elected as a Class II director for Quantum-Si.
What new role has Dr. Jonathan Rothberg taken on?
Dr. Jonathan Rothberg has been appointed as the Chief Scientific Officer.
What is the date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is March 20, 2024.
What are the main items covered in this 8-K filing?
This filing covers the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers.
What is the state of incorporation for Quantum-Si Incorporated?
Quantum-Si Incorporated is incorporated in Delaware.
Filing Stats: 867 words · 3 min read · ~3 pages · Grade level 9.7 · Accepted 2024-03-21 16:14:34
Key Financial Figures
- $0.0001 — stered Class A common stock, par value $0.0001 per share QSI The Nasdaq Stock Mark
- $11.50 — mon stock, each at an exercise price of $11.50 per share QSIAW The Nasdaq Stock Ma
Filing Documents
- ef20024742_8k.htm (8-K) — 34KB
- ef20024742_ex99-1.htm (EX-99.1) — 13KB
- image00001.jpg (GRAPHIC) — 6KB
- 0001140361-24-014618.txt ( ) — 236KB
- qsi-20240320.xsd (EX-101.SCH) — 4KB
- qsi-20240320_def.xml (EX-101.DEF) — 18KB
- qsi-20240320_lab.xml (EX-101.LAB) — 27KB
- qsi-20240320_pre.xml (EX-101.PRE) — 20KB
- ef20024742_8k_htm.xml (XML) — 6KB
02
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Appointment of Paula Dowdy to the Board of Directors On March 20, 2024, the Board of Directors (the "Board") of Quantum-Si Incorporated (the "Company") appointed Paula Dowdy to the Board, effective as of March 21, 2024. Ms. Dowdy will serve for a term to continue until the Company's next annual meeting of stockholders. Ms. Dowdy, age 58, has over 35 years of global commercial and operational experience. In additional to her role on our Board, Ms. Dowdy is an independent director of SPT Labtech, a world leading lab automation tools company, a position she has held since March 2023. Paula also served on the board as an independent director at AVEVA Group plc, a global publicly traded software company, from March 2019 to March 2023. Ms. Dowdy previously held the position of Senior Vice President and General Manager for Europe, Middle East and Africa at Illumina, Inc., from August 2016 to January 2023. Ms. Dowdy also spent over 20 years at Cisco Systems, Inc., and held various positions in products, services, and software in the United States, and globally, with her last role as Senior Vice President. Ms. Dowdy is a graduate of the University of California, Berkeley, where she earned her B.A. and she received an M.B.A. from Pepperdine University. Ms. Dowdy's qualifications to serve on our Board include her extensive experience in leadership roles at other biotechnology and technology companies. The Board has affirmatively determined that Ms. Dowdy is an independent director pursuant to the Nasdaq Stock Market listing rules. There are no arrangements or understandings between Ms. Dowdy and any other person pursuant to which Ms. Dowdy was appointed as a director. There are no transactions between Ms. Dowdy and the Company that would be reportable under Item 404(a) of Regulation S-K. Ms. Dowdy has not previously
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release dated March 21, 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. QUANTUM-SI INCORPORATED By: /s/ Christian LaPointe, Ph.D. Name: Christian LaPointe, Ph.D. Title: General Counsel Date: March 21, 2024